Sensus Healthcare Statistics
Total Valuation
SRTS has a market cap or net worth of $57.12 million. The enterprise value is $39.20 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SRTS has 16.46 million shares outstanding. The number of shares has decreased by -0.05% in one year.
| Current Share Class | 16.46M |
| Shares Outstanding | 16.46M |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | +0.84% |
| Owned by Insiders (%) | 17.70% |
| Owned by Institutions (%) | 27.73% |
| Float | 13.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.54 |
| Forward PS | 2.57 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.27, with a Debt / Equity ratio of 0.01.
| Current Ratio | 7.27 |
| Quick Ratio | 3.74 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -15.77% and return on invested capital (ROIC) is -44.43%.
| Return on Equity (ROE) | -15.77% |
| Return on Assets (ROA) | -13.44% |
| Return on Invested Capital (ROIC) | -44.43% |
| Return on Capital Employed (ROCE) | -26.31% |
| Weighted Average Cost of Capital (WACC) | 10.74% |
| Revenue Per Employee | $375,533 |
| Profits Per Employee | -$129,550 |
| Employee Count | 60 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 0.81 |
Taxes
| Income Tax | -3.62M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.20% in the last 52 weeks. The beta is 1.19, so SRTS's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -22.20% |
| 50-Day Moving Average | 4.01 |
| 200-Day Moving Average | 3.93 |
| Relative Strength Index (RSI) | 39.70 |
| Average Volume (20 Days) | 83,488 |
Short Selling Information
The latest short interest is 309,316, so 1.88% of the outstanding shares have been sold short.
| Short Interest | 309,316 |
| Short Previous Month | 422,044 |
| Short % of Shares Out | 1.88% |
| Short % of Float | 2.28% |
| Short Ratio (days to cover) | 11.18 |
Income Statement
In the last 12 months, SRTS had revenue of $22.53 million and -$7.77 million in losses. Loss per share was -$0.48.
| Revenue | 22.53M |
| Gross Profit | 8.50M |
| Operating Income | -12.02M |
| Pretax Income | -11.40M |
| Net Income | -7.77M |
| EBITDA | -11.62M |
| EBIT | -12.02M |
| Loss Per Share | -$0.48 |
Full Income StatementBalance Sheet
The company has $18.33 million in cash and $407,000 in debt, with a net cash position of $17.92 million or $1.09 per share.
| Cash & Cash Equivalents | 18.33M |
| Total Debt | 407,000 |
| Net Cash | 17.92M |
| Net Cash Per Share | $1.09 |
| Equity (Book Value) | 45.54M |
| Book Value Per Share | 2.77 |
| Working Capital | 36.73M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 396,500 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 37.74%, with operating and profit margins of -53.34% and -34.50%.
| Gross Margin | 37.74% |
| Operating Margin | -53.34% |
| Pretax Margin | -50.57% |
| Profit Margin | -34.50% |
| EBITDA Margin | -51.58% |
| EBIT Margin | -53.34% |
| FCF Margin | n/a |
Dividends & Yields
SRTS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 0.05% |
| Earnings Yield | -13.61% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for SRTS is $6.25, which is 80.12% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.25 |
| Price Target Difference | 80.12% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |
